Inflammatory paradoxical reaction occurring in tuberculosis patients treated with HAART and rifampicin

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 44, Issue 2, 2002, Pages 113-114

  Fernandes, Georgia Claudia T S ^a   Vieira, Maria Armanda M S ^a   Lourenço, Maria Cristina ^a   Gadelha, Ângela J ^b   Coura, Lea C ^a   Rolla, Valeria C ^a  

^a Funda??o Oswaldo Cruz   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; RIFAMPICIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CASE REPORT; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; LETTER; MALE; TUBERCULOMA; TUBERCULOSIS; VIRUS LOAD;

EID: 0036090555     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-46652002000200011     Document Type: Letter

References (9)

1. Paradoxical expansive lesions of cerebral tuberculosis during antitubercular drug therapy
2. Antiretroviral therapy in adults; updated recommendations of the International AIDS Society-USA Panel
3. Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extmpulmonary tuberculosis
4. Notice to readers: Updated guidelines for the use of Rifabutin or Rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or non nucleoside reverse transcriptase inhibitors
5. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease
6. Opportunistic infections shortly after beginning highly active antiretroviral therapy
7. +cell counts in the protease inhibitors era
8. Paradoxical reaction syndrome complicating aural infection due to Mycobacterium tuberculosis during therapy